Previous Close | 3.4200 |
Open | 3.4300 |
Bid | 3.2500 x 3200 |
Ask | 3.4000 x 1800 |
Day's Range | 3.2000 - 3.4637 |
52 Week Range | 1.7700 - 14.7890 |
Volume | |
Avg. Volume | 574,404 |
Market Cap | 133.556M |
Beta (5Y Monthly) | 2.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.5480 |
Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for VRCA
Zoetis' (ZTS) earnings miss estimates in second-quarter 2022. The revenues beat estimates owing to the strong uptake of the company's companion animal portfolio products.
Pacira's (PCRX) earnings and revenues fall shy of estimates in the second quarter of 2022.
United Therapeutics' (UTHR) second-quarter earnings missed estimates, while sales beat the same. Higher sales of Orenitram and Tyvaso drove the top line in the quarter.